Searched for
DRUG FIRM PFIZER
Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- Drug firm Pfizer's Managing Director S Sridhar resignsHe will continue to serve in his current position until the identification, selection and transition to the new leadership takes place in t...
- Pfizer Q1 rsults: Net profit rises 10% to Rs 124.45 crThe company had posted a net profit of Rs 112.81 crore for the corresponding period of the previous fiscal, Pfizer Ltd said in a BSE filing.
- Pfizer Q3 net profit up 5% to Rs 139 croreShares of Pfizer Ltd were trading at Rs 4,350 per scrip on BSE, down 5.24 per cent.
- Pfizer to reportedly sign a deal to buy Allergan for $150 billion; to be drug industry's biggest dealUS drug giant Pfizer is reportedly moving closer to sign a deal to buy Botox maker Allergan for $150 billion, or about Rs 9,88,000 crore.
- Drug firm Pfizer to close its Navi Mumbai plantPfizer said that decision to close the plant is based on an assessment of its long term viability and its ability to achieve the needed pro...
- Drug firm Pfizer gets Bombay High Court nod for merger of Wyeth LtdIn November last year Pfizer and Wyeth had said they will merge their India operations under a single brand as part of efforts to boost bus...
- Pfizer issues lockout notice at Thane plant"Pfizer has been forced to issue a lockout notice at its Thane manufacturing plant to ensure the safety of our colleagues"
- Indian patent law doesn't discriminate against US companies: IPAIndian Pharma Alliance (IPA) writes to Roy Waldron after he slammed country's IP policy as protectionist and discriminatory.
- Lupin to challenge Pregabalin ruling by US courtLupin Limited says it will challenge a US court order that prevents it from selling a low-cost generic version of Pfizer's nerve pain drug ...
- Watson Pharma launches Lipitor genericWatson’s launch raises questions on India’s third-largest drug company Ranbaxy Laboratories’ revenues from the drug.
- Dr Reddy's to contest Pfizer's patent suit over atorvastatinDrug maker Dr Reddy's Laboratories will contest the patent infringement case filed against it by the global pharmaceutical giant Pfizer ove...
- Pfizer deal buzz lifts Biocon to 52-wk highBiocon surged on buzz that Pfizer is in talks to buy a stake or strike a marketing alliance with it.
- Pfizer scans India for shopping optionsPfizer has approached several Indian drugmakers for possible alliances as part of moves to try and bolster revenues threatened by the expir...
- Pfizer may go all out for RanbaxyA rumoured counter-bid by Pfizer for Ranbaxy is eerily similar to the US firm’s actions in November 1999 when it launched an aggressive bid...
- Ranbaxy shares rise on buzz of Pfizer 'counter-offer'The share price of Ranbaxy Laboratories rose to a 3-year high on Friday based on the rumour that the world’s largest drug maker, Pfizer, ma...
- Netherlands court stops Ranbaxy from launching LipitorAn appellate court in the Netherlands has restrained India's largest drug firm Ranbaxy Laboratories Ltd from launching a generic version of...
Load More
